Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Nuclear Medicine

Free Subscription 12.01.2026 2 AJNR Am J Neuroradiol 3 Ann Nucl Med 1 Brain 21 Clin Nucl Med 1 J Cereb Blood Flow Metab 6 J Nucl Med 1 Neurology 8 Nucl Med Commun 2 Phys Med Biol 1 PLoS One 1 Semin Nucl Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. TU RK, Esposito G, Agarwal A, Akin EA, et al
   ACR-ACNM-ASNR-SNMMI Practice Parameter for the Performance of Brain PET/CT Imaging in Dementia.
   AJNR Am J Neuroradiol. 2026 Jan 8. doi: 10.3174/ajnr.A9105.
   PubMed         Abstract available
   
   
2. FRIEDRICHSEN KA, Judge BA, Jones LA, Rajamanickam J, et al
   Evaluation of [(11)C]CS1P1 in Healthy Young and Older Adults.
   AJNR Am J Neuroradiol. 2026;47:175-183.
   PubMed         Abstract available
   
   

   
   Ann Nucl Med

3. MESFIN B, Ishioka Y, Ichinose Y, Inamura A, et al
   Whole-body biodistribution of [(18)F]SMBT-1: a novel PET tracer for monoamine oxidase B imaging in healthy humans.
   Ann Nucl Med. 2026 Jan 7. doi: 10.1007/s12149-025-02144.
   PubMed        
   
   
4. MANSOURI Z, Salimi Y, Wolf NB, Hajianfar G, et al
   Deep learning-guided attenuation and scatter correction of (99m)Tc-MAA SPECT images: towards quantitative analysis in (90)Y-SIRT.
   Ann Nucl Med. 2026 Jan 5. doi: 10.1007/s12149-025-02152.
   PubMed         Abstract available
   
   
5. AGHAZADA F, Uslu-Besli L, Kibar A, Sahin OE, et al
   Effect of previous (177)Lu-DOTATATE treatment on (90)Y-microsphere treatment response in neuroendocrine tumor patients with liver metastasis.
   Ann Nucl Med. 2026;40:41-49.
   PubMed         Abstract available
   
   

   
   Brain

6. KALINOWSKI A, Steinman L
   The complexity of interpreting TSPO PET neuroimaging in first-episode psychosis.
   Brain. 2026 Jan 8:awaf476. doi: 10.1093.
   PubMed        
   
   

   
   Clin Nucl Med

7. DILEK I, Nayman A, Onner H
   Rarely Seen, Highly Significant: Aberrant Distal Esophageal Artery in TARE Treatments.
   Clin Nucl Med. 2026;51:e134-e135.
   PubMed         Abstract available
   
   
8. RAEISI N, Saber Tanha A, Aryana K, Soltani E, et al
   99m Tc-FAPI-46 Scintigraphy in Recurrence of Low-Grade Myofibroblastic Sarcoma.
   Clin Nucl Med. 2026;51:e138-e139.
   PubMed         Abstract available
   
   
9. ALBOOYEH H, Amini H, Arefnia M, Aldarraji MA, et al
   177 Lutetium-PSMA Therapy in a Patient With Concurrent Prostate Cancer and Renal Cell Carcinoma.
   Clin Nucl Med. 2026;51:e111-e113.
   PubMed         Abstract available
   
   
10. DHARMASHAKTU Y, Tripathi M, Ballal S, Haresh KP, et al
    Targeted Radionuclide Therapy in Diffuse Intrinsic Brainstem Gliomas: Exploring Options Beyond the Finish Line.
    Clin Nucl Med. 2026;51:e140-e141.
    PubMed         Abstract available
    
    
11. WENG D, Gao P
    Intravascular Large B-cell Lymphoma With Multisystem Involvement.
    Clin Nucl Med. 2026;51:e126-e128.
    PubMed         Abstract available
    
    
12. RAEISI N, Saber Tanha A, Askari E, Bari A, et al
    99m Tc-FAPI-46 Uptake in Medication-Related Jaw Osteonecrosis.
    Clin Nucl Med. 2026;51:e114-e116.
    PubMed         Abstract available
    
    
13. ZHAO Y, Guo X, Tan M, Xu T, et al
    Increased 68Ga-FAPI Uptake of Nasal Polyp in a Patient With Lung Cancer.
    Clin Nucl Med. 2025 Jul 21. doi: 10.1097/RLU.0000000000006068.
    PubMed         Abstract available
    
    
14. XIAO Z, Dong A, Wang Y, Bai Y, et al
    Inter-tumor Heterogeneity of 68 Ga-PSMA-11 Uptake in Metastatic Undifferentiated Sarcoma.
    Clin Nucl Med. 2026;51:173-175.
    PubMed         Abstract available
    
    
15. NAZERANI-ZEMANN T, Gstettner C, Tsybrovskyy O, Stranger N, et al
    When Benign Is Not Simple: Suspicious Thyroid Scintigraphy Revealing PTEN Hamartoma Tumor Syndrome in a Pediatric Patient.
    Clin Nucl Med. 2025 Sep 10. doi: 10.1097/RLU.0000000000006090.
    PubMed         Abstract available
    
    
16. SUN Y, Jiang J, Meng Q, Wang W, et al
    68Ga-FAPI-04: A Powerful Tool for Detecting Subcentimeter Metastases of Intrahepatic Cholangiocarcinoma.
    Clin Nucl Med. 2025 Sep 18. doi: 10.1097/RLU.0000000000006114.
    PubMed         Abstract available
    
    
17. DUAN R, Cai X, Zheng L, Bian Y, et al
    Hepatic Metastasis From Duodenal Ampullary Carcinoma With Intense FAP Activity But Without FDG Uptake.
    Clin Nucl Med. 2026;51:164-165.
    PubMed         Abstract available
    
    
18. LIU F, Yang X, Xiao L, Zhu Z, et al
    The Effectiveness of Low-dose 161 Tb-PSMA Treatment for Metastatic Castration-resistant Prostate Cancer.
    Clin Nucl Med. 2026;51:166-167.
    PubMed         Abstract available
    
    
19. PHILLIPS I, Chen J, Milhem M, DiCamillo P, et al
    Vascular Leiomyosarcoma Masquerading as Chronic Deep Venous Thrombosis.
    Clin Nucl Med. 2026;51:132-133.
    PubMed         Abstract available
    
    
20. QI N, Ding J, Cheng X, Zhao J, et al
    Negative 18F-FDG and Positive 68Ga-FAPI-04 Findings in a Patient With Acute Cholangitis.
    Clin Nucl Med. 2025 Dec 15. doi: 10.1097/RLU.0000000000006225.
    PubMed         Abstract available
    
    
21. WANG K, Pu J, Xiang K, Liu Y, et al
    18 F-FDG Uptake Outperforms 68 Ga-FAPI in Mediastinal NUT Carcinoma.
    Clin Nucl Med. 2026;51:151-153.
    PubMed         Abstract available
    
    
22. MAN X, Dong C, Dong A, Song X, et al
    Intense 68Ga-PSMA-11 Uptake of Perihilar Cholangiocarcinoma.
    Clin Nucl Med. 2025 Dec 22. doi: 10.1097/RLU.0000000000006107.
    PubMed         Abstract available
    
    
23. ZHANG Z, Guo Z, Zuo C, Zhu L, et al
    Unexpected 18 F-PSMA-1007 Uptake in a Colonic Diverticulum : A Benign Mimicker of Metastatic Prostate Cancer.
    Clin Nucl Med. 2026;51:179-180.
    PubMed         Abstract available
    
    
24. KASSAS M, Artigas C, Refalo N, Mallia A, et al
    Added Value of Interim FDG PET/CT in Resolving PSA-PSMA Discordance during PSMA-targeted Radioligand Therapy.
    Clin Nucl Med. 2026;51:191-193.
    PubMed         Abstract available
    
    
25. SHAO G, Kaiser B, Gabriel M, Lamprecht B, et al
    Prognostic Implications of Volume-based Quantitative 18F-FDG PET/CT Biomarkers in Pulmonary Sarcoidosis.
    Clin Nucl Med. 2026;51:91-98.
    PubMed         Abstract available
    
    
26. TAO Z, Chen X, Tang Q, Duan X, et al
    Noninvasive Evaluation of HER2 Expression and Heterogeneity in Urothelial Carcinoma on 68Ga-HER2-affibody PET/CT.
    Clin Nucl Med. 2026;51:99-107.
    PubMed         Abstract available
    
    
27. PREET K, Sood A, Satapathy S, Goyal S, et al
    68Ga-PSMA-11 PET/CT Versus Conventional Imaging for Response Evaluation in Metastatic Castration-resistant Prostate Cancer: A Single-center Prospective Study.
    Clin Nucl Med. 2026;51:e100-e107.
    PubMed         Abstract available
    
    

    
    J Cereb Blood Flow Metab

28. SZABO V, Mesnildrey Q, Dargazanli C, Kucharczak F, et al
    Spatiotemporal dynamics of computed tomography perfusion (CTP) parameters following aneurysmal subarachnoid hemorrhage (SAH).
    J Cereb Blood Flow Metab. 2026;46:91-104.
    PubMed         Abstract available
    
    

    
    J Nucl Med

29. SHANG C, Nagao R, Riku Y, Ichihara T, et al
    Serotonin Transporter Distribution in the Brainstem of Multiple-System Atrophy-Parkinsonian Type: Insights from Pathology and (123)I-FP-CIT SPECT Findings.
    J Nucl Med. 2026 Jan 8:jnumed.124.268669. doi: 10.2967/jnumed.124.268669.
    PubMed         Abstract available
    
    
30. WERNER JM, Lohmann P, Kabbasch C, Wollring MM, et al
    Assessment of Response to Regorafenib in Patients with Glioma Relapse Using (18)F-FET PET and MRI.
    J Nucl Med. 2026 Jan 8:jnumed.125.270946. doi: 10.2967/jnumed.125.270946.
    PubMed         Abstract available
    
    
31. KESSLER L, Schwaning F, Metzenmacher M, Pabst KM, et al
    Prognostic Value of Fibroblast Activation Protein-Directed PET Imaging in Pleural Mesothelioma.
    J Nucl Med. 2026 Jan 8:jnumed.125.270906. doi: 10.2967/jnumed.125.270906.
    PubMed         Abstract available
    
    
32. CHRISTENSEN TN, Langer SW, Dejanovic D, Gillings N, et al
    Malignancy Detection Rates of [(68)Ga]Ga-SSO120 PET/CT in Patients with Small Cell Lung Cancer and Large Cell Neuroendocrine Lung Cancer.
    J Nucl Med. 2026 Jan 8:jnumed.125.270233. doi: 10.2967/jnumed.125.270233.
    PubMed         Abstract available
    
    
33. ABDEL-WAHAB M, Giammarile F
    Nuclear Medicine and External Beam Radiation Therapy in Prostate Cancer: A Synergistic Approach.
    J Nucl Med. 2026 Jan 8:jnumed.125.271268. doi: 10.2967/jnumed.125.271268.
    PubMed         Abstract available
    
    
34. AKCA U, Song PN, Devalankar D, Yasui N, et al
    Preclinical Comparison of (18)F-Labeled Amino Acids Targeting Different Transporter Systems for PET Imaging of Triple-Negative Breast Cancer.
    J Nucl Med. 2026 Jan 8:jnumed.125.270225. doi: 10.2967/jnumed.125.270225.
    PubMed         Abstract available
    
    

    
    Neurology

35. SUN Y, Na HK, Jeon S, Ye BS, et al
    Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase (18)F-FP-CIT PET Study.
    Neurology. 2026;106:e214573.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

36. SEKER K, Aydos U, Ucar M, Akdemir UO, et al
    Relationship between anatomical, functional, and metabolic parameters obtained from pelvic MRI and whole-body 18F-FDG PET/MRI and distant metastatic disease in primary rectal adenocarcinoma.
    Nucl Med Commun. 2026 Jan 6. doi: 10.1097/MNM.0000000000002099.
    PubMed         Abstract available
    
    
37. ARSLAN E, Nisli S, Baydemir I, Yilmaz Bildik B, et al
    Diagnostic and prognostic importance of 18F-fluorodeoxyglucose PET/computed tomography in primary extranodal and atypically presenting lymphomas.
    Nucl Med Commun. 2026 Jan 6. doi: 10.1097/MNM.0000000000002096.
    PubMed         Abstract available
    
    
38. SAJU A, Sonavane S, Basu S
    [18F]fluorodeoxyglucose PET/computed tomography imaging in coronary artery stent infection and related complications alongside conventional investigative modalities: evolving the best practices for diagnosis and treatment response monitoring.
    Nucl Med Commun. 2026 Jan 6. doi: 10.1097/MNM.0000000000002095.
    PubMed         Abstract available
    
    
39. GUO C, Tong Y, Zhang P, Li X, et al
    Independent prognostic value and clinical significance of 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters in predicting overall survival of patients with glioma.
    Nucl Med Commun. 2026;47:206-213.
    PubMed         Abstract available
    
    
40. MUTLU E, Senisik AM, Kovan B, Kuyumcu S, et al
    Threshold optimization for lesion size in lutetium-177 single-photon emission computed tomography imaging: a phantom-based evaluation.
    Nucl Med Commun. 2026;47:160-167.
    PubMed         Abstract available
    
    
41. JAMAATI S, Dorri Giv M, Hong X, Sadeghi R, et al
    Sparse-view reconstruction and noise reduction in 99m Tc-prostate specific membrane antigen prostate imaging.
    Nucl Med Commun. 2026;47:185-196.
    PubMed         Abstract available
    
    
42. BARBOSA N, Granados C, Pulido E, Zuluaga C, et al
    Concordance between single-time-point and multiple-time-point dosimetry in 177 Lu-PSMA-I&T therapy for metastatic castration-resistant prostate cancer.
    Nucl Med Commun. 2026;47:153-159.
    PubMed         Abstract available
    
    
43. EMERSON RP, Agrawal K, Sradha Patro PS, Singh P, et al
    Role of 99m Tc-sestamibi single photon emission computed tomography/computed tomography in the characterization of renal lesions: a prospective observational study.
    Nucl Med Commun. 2026;47:133-142.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

44. SOLETI SR, Dietz PE, Esteve R, Garcia-Barrena J, et al
    CRYSP: a total-body PET based on cryogenic cesium iodide crystals.
    Phys Med Biol. 2026 Jan 8. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    
45. NUYTS J, Defrise M, Morel C, Lecoq P, et al
    Corrigendum: How the sensitivity of TOF-PET depends on the interplay between the temporal and spatial detector resolutions and the resolution required for the imaging task (2025Phys. Med. Biol.70 245001).
    Phys Med Biol. 2026;71.
    PubMed        
    
    

    
    PLoS One

46. STARIC D, Arnauer L, Marshall-Pescini S, Range F, et al
    Influence of agility training on body-size and object solidity perception in pet dogs.
    PLoS One. 2026;21:e0338647.
    PubMed         Abstract available
    
    

    
    Semin Nucl Med

47. VORSTER M, Sathekge M
    (18)F-FDG PET/CT for prediction of response in breast cancer.
    Semin Nucl Med. 2026 Jan 8:S0001-2998(25)00173.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.